WDB coco Co., Ltd. AI Stock Analysis
Want to see JP:7079 full AI Analyst Report?
WDB coco Co., Ltd. (7079) AI Stock Analysis
WDB coco Co., Ltd.
(TSE/TYO:7079)
The score is driven primarily by strong financial fundamentals (especially the low-debt balance sheet) and very attractive valuation (low P/E and a ~3.75% dividend yield). These positives are partially offset by weaker technical setup (below key moving averages and negative MACD) and signs of a recent FY2026 slowdown in revenue and cash generation.
WDB coco Co., Ltd. (7079) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 6.04B
- Dividend Yield
- 3.82%
- Average Volume (3M)
- 1,750
- Price to Earnings (P/E)
- 0.9
- Beta (1Y)
- 0.21
- Revenue Growth
- -8.78%
- EPS Growth
- 0.01%
- Country
- Japan
- Employees
- 516
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Specialty Business Services
WDB coco Co., Ltd. Business Overview & Revenue Model
Company Description
WDB coco Co., Ltd. offers specialized contractual services to pharmaceutical companies throughout Japan. The firm plays a crucial role in advancing pharmaceuticals and medical devices, with a particular focus on safety information management, support...
How the Company Makes Money
null
WDB coco Co., Ltd. Financial Statement Overview
Summary
Financial quality is strong overall, led by an exceptionally conservative balance sheet (very low leverage and solid ROE). Profitability remains healthy, but FY2026 showed a clear slowdown with revenue down ~9.2% and weaker cash generation versus prior peaks, which tempers the score.
Income Statement
78PositiveBalance Sheet
92Very PositiveCash Flow
74Positive| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 54.01B | 4.82B | 5.33B | 4.60B | 4.07B | 3.62B |
| Gross Profit | 18.39B | 1.71B | 2.07B | 1.93B | 1.58B | 1.44B |
| EBITDA | 9.65B | 1.01B | 1.36B | 1.31B | 1.12B | 981.71M |
| Net Income | 6.62B | 679.31M | 912.90M | 857.83M | 743.63M | 647.70M |
Balance Sheet | ||||||
| Total Assets | 5.93B | 5.70B | 5.60B | 4.67B | 3.67B | 3.14B |
| Cash, Cash Equivalents and Short-Term Investments | 4.19B | 3.76B | 3.48B | 2.66B | 2.00B | 1.89B |
| Total Debt | 0 | 80.41M | 29.81M | 27.12M | 24.32M | 33.52M |
| Total Liabilities | 1.05B | 921.26M | 1.30B | 1.10B | 866.02M | 994.57M |
| Stockholders Equity | 4.89B | 4.78B | 4.30B | 3.56B | 2.80B | 2.15B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 521.82M | 1.10B | 753.84M | 469.46M | 719.72M |
| Operating Cash Flow | 0 | 570.54M | 1.10B | 772.20M | 517.49M | 747.90M |
| Investing Cash Flow | 0 | -80.53M | -88.33M | -91.82M | -302.97M | -60.48M |
| Financing Cash Flow | 0 | -207.03M | -195.83M | -110.94M | -101.21M | -79.11M |
WDB coco Co., Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7079, the sentiment is Negative. The current price of 2485.00 is below the 20-day moving average (MA) of 2543.25, below the 50-day MA of 2564.38, and below the 200-day MA of 2589.79, indicating a bearish trend. The MACD of -11.45 indicates Positive momentum. The RSI at 44.03 is Neutral, neither overbought nor oversold. The STOCH value of 51.72 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7079.
WDB coco Co., Ltd. Peers Comparison
Overall Rating
JP:707977Outperform
JP:458248Neutral
JP:453946.5Neutral
JP:458646Neutral
JP:488343Neutral
JP:489242Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 77Outperform | JPY 5.98B | 0.91 | ― | 3.82% | -8.78% | 0.01% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 48Neutral | JPY 7.16B | -0.82 | ― | ― | -30.58% | 6.93% | |
| 47Neutral | JPY 5.57B | -11.41 | ― | 3.24% | 0.31% | -194.72% | |
| 46Neutral | JPY 3.71B | -3.58 | ― | ― | -81.42% | 36.56% | |
| 43Neutral | JPY 3.73B | -1.41 | ― | ― | ― | 25.34% | |
| 42Neutral | JPY 5.08B | -6.53 | ― | ― | 214.65% | 22.18% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:7079 | WDB coco Co., Ltd. | 2485.00 | -3.98 | -0.16% | |
| JP:4539 | Nippon Chemiphar Co., Ltd. | 1543.00 | 68.97 | 4.68% | |
| JP:4582 | Symbio Pharmaceuticals Limited | 71.00 | -33.00 | -31.73% | |
| JP:4586 | Medrx Co., Ltd. | 47.00 | -75.00 | -61.48% | |
| JP:4883 | Modalis Therapeutics Corporation | 31.00 | -36.00 | -53.73% | |
| JP:4892 | Cyfuse Biomedical K.K. | 515.00 | -69.00 | -11.82% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 17, 2026
